Virios Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VIRI and other ETFs, options, and stocks.

About VIRI

Virios Therapeutics, Inc. engages in pharmaceutical products for fibromyalgia and other related conditions. The firm engages in the development and commercialization of antiviral therapies to treat diseases associated with a viral triggered abnormal immune response including fibromyalgia.

CEO

Gregory Duncan

CEOGregory Duncan

Employees

Employees4

Headquarters

Alpharetta, Georgia

HeadquartersAlpharetta, Georgia

Founded

2012

Founded2012

Employees

Employees4

VIRI Key Statistics

Market cap

8.11M

Market cap8.11M

Price-Earnings ratio

-1.49

Price-Earnings ratio-1.49

Dividend yield

—

Dividend yield—

Average volume

79.27K

Average volume79.27K

High today

—

High today—

Low today

—

Low today—

Open price

$0.445

Open price$0.445

Volume

0.00

Volume0.00

52 Week high

$2.42

52 Week high$2.42

52 Week low

$0.279

52 Week low$0.279

Virios Therapeutics

Why Robinhood?

Virios Therapeutics, Inc. engages in pharmaceutical products for fibromyalgia and other related conditions. The firm engages in the development and commercialization of antiviral therapies to treat diseases associated with a viral triggered abnormal immune response including fibromyalgia. Show more

VIRI Key Statistics

Virios Therapeutics, Inc. engages in pharmaceutical products for fibromyalgia and other related conditions. The firm engages in the development and commercialization of antiviral therapies to treat diseases associated with a viral triggered abnormal immune response including fibromyalgia.